EcoDrugPlus

Ribosomal Protein Lateral Stalk Subunit P0

Ensembl ID : ENSFHEG00000003767
Gene Symbol: RPLP0
3 Cross references
403 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P1

Ensembl ID : ENSFHEG00000008862
Gene Symbol: RPLP1
3 Cross references
386 Possible Orthologues:

Selectin E

Ensembl ID : ENSFHEG00000022594
Gene Symbol: SELE
3 Cross references
180 Possible Orthologues:

Serine/threonine-Protein Kinase A-Raf

Ensembl ID : ENSFHEG00000022191
Gene Symbol: LOC105915654
3 Cross references
191 Possible Orthologues:

Serine/threonine-Protein Kinase D3-Like

Ensembl ID : ENSFHEG00000012788
Gene Symbol: LOC105934406
2 Cross references
207 Possible Orthologues:

Serine/threonine-Protein Kinase Pim-1

Ensembl ID : ENSFHEG00000015016
Gene Symbol: LOC105915239
3 Cross references
250 Possible Orthologues:

Serpin Family C Member 1

Ensembl ID : ENSFHEG00000002623
Gene Symbol: SERPINC1
3 Cross references
202 Possible Orthologues:

Serum Amyloid P-Component-Like

Ensembl ID : ENSFHEG00000017456
Gene Symbol: LOC105926391
2 Cross references
356 Possible Orthologues:

Si:dkey-211g8.6

Ensembl ID : ENSFHEG00000016222
Gene Symbol: SI:DKEY-211G8.6
1 Cross references
319 Possible Orthologues:

Sigma Non-Opioid Intracellular Receptor 1

Ensembl ID : ENSFHEG00000005490
Gene Symbol: SIGMAR1
3 Cross references
205 Possible Orthologues:

Sirtuin 1

Ensembl ID : ENSFHEG00000007557
Gene Symbol: SIRT1
3 Cross references
158 Possible Orthologues:

Smoothened, Frizzled Class Receptor

Ensembl ID : ENSFHEG00000020112
Gene Symbol: SMO
3 Cross references
204 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).